Haemonetics Corporation (HAE)
Who owns Haemonetics Corporation (HAE)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 98.7% of the shares are freely tradable; institutional investors hold 108.4%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 12.37 | 5,619,979 | -3.5 | 03/31/2026 |
| Neuberger Berman Group LLC | 7.84 | 3,560,918 | -7.9 | 03/31/2026 |
| AQR Capital Management LLC | 7.39 | 3,356,543 | +6.1 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 5.63 | 2,559,316 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.60 | 2,090,389 | +0.0 | 03/31/2026 |
| State Street Corp | 3.90 | 1,772,898 | +2.5 | 03/31/2026 |
| Arrowstreet Capital Limited Partnership | 3.04 | 1,383,004 | +0.2 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 3.50 | 1,590,023 | +0.2 | 07/28/2026 |
| Neuberger Genesis Inv | 3.28 | 1,491,533 | +22.1 | 06/30/2026 |
| Vanguard Morn Total Stk Mkt Idx Investor | 3.17 | 1,441,997 | -2.7 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 24. Jul 2026 | Madaus Martin D | Director | Other | 2,538 | – | – |
| 24. Jul 2026 | Zane Ellen M | Director | Other | 2,538 | – | – |
| 24. Jul 2026 | Pomeroy Claire | Director | Other | 2,538 | – | – |
| 24. Jul 2026 | Kroll Mark W | Director | Other | 2,538 | – | – |
| 24. Jul 2026 | Johnson Lloyd Emerson | Director | Other | 2,538 | – | – |
| 24. Jul 2026 | Coyle Michael J | Director | Other | 2,538 | – | – |
| 24. Jul 2026 | Bryant Diane M | Director | Other | 2,538 | – | – |
| 24. Jul 2026 | Abernathy Robert E | Director | Other | 2,538 | – | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.